Autonomix Medical, Inc. Common Stock
AMIX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $2 | $0 | $48 | $0 |
| Gross Profit | -$2 | $0 | -$48 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2,367 | $1,593 | $1,553 | $1,044 |
| G&A Expenses | $0 | $1,828 | $0 | $1,703 |
| SG&A Expenses | $5,165 | $1,828 | $1,651 | $1,703 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $7,532 | $3,421 | $3,204 | $2,747 |
| Operating Income | -$7,534 | -$3,421 | -$3,252 | -$2,747 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $83 | $84 | $61 | $35 |
| Pre-Tax Income | -$7,451 | -$3,337 | -$3,191 | -$2,712 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7,451 | -$3,337 | -$3,191 | -$2,712 |
| % Margin | – | – | – | – |
| EPS | -1.38 | -1.07 | -1.81 | -1.46 |
| % Growth | -29% | 40.9% | -24% | – |
| EPS Diluted | -1.38 | -1.07 | -1.81 | -1.46 |
| Weighted Avg Shares Out | 5,412 | 3,105 | 1,766 | 1,852 |
| Weighted Avg Shares Out Dil | 5,412 | 3,105 | 1,766 | 1,852 |
| Supplemental Information | – | – | – | – |
| Interest Income | $83 | $84 | $107 | $80 |
| Interest Expense | $0 | $0 | $46 | $45 |
| Depreciation & Amortization | $2 | $3 | $48 | $47 |
| EBITDA | -$7,449 | -$3,334 | -$3,097 | -$2,620 |
| % Margin | – | – | – | – |